| NCT00003574 |
|
Radiation Therapy in Treating Patients With Progressive or Recurrent Malignant Brain Tumors
|
View
|
| NCT00003573 |
|
Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma
|
View
|
| NCT00003572 |
|
Total-Body Irradiation Tacrolimus and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers
|
View
|
| NCT00003571 |
|
Gene Testing in Patients With Colon Cancer
|
View
|
| NCT00003569 |
|
Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and Paclitaxel
|
View
|
| NCT00003568 |
|
Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma
|
View
|
| NCT00003567 |
|
Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkins Lymphoma
|
View
|
| NCT00003566 |
|
Thoracoscopy in Patients With Stage IIIA Non-Small Cell Lung Cancer
|
View
|
| NCT00003565 |
|
Docetaxel in Treating Patients With Solid Tumors
|
View
|
| NCT00003564 |
|
Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas
|
View
|
| NCT00003563 |
|
Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Brain Metastases
|
View
|
| NCT00003562 |
|
Docetaxel Plus Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
|
View
|
| NCT00003561 |
|
Interferon Alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
|
View
|
| NCT00003560 |
|
Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian Fallopian Tube or Primary Peritoneal Cancer
|
View
|
| NCT00003558 |
|
Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin
|
View
|
| NCT00003557 |
|
Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver Bile Duct or Gallbladder Cancer
|
View
|
| NCT00003556 |
|
Vaccine Therapy in Treating Patients With Melanoma
|
View
|
| NCT00003555 |
|
Paclitaxel Plus Chemoprotection With Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors
|
View
|
| NCT00003554 |
|
Rituximab in Treating Patients With Multiple Myeloma
|
View
|
| NCT00003553 |
|
Peripheral Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer
|
View
|
| NCT00003552 |
|
Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Melanoma
|
View
|
| NCT00003551 |
|
Aminocamptothecin in Treating Patients With Advanced or Recurrent Kidney Cancer
|
View
|
| NCT00003549 |
|
S9716 Combination Chemotherapy in Treating Patients With Merkel Cell Cancer
|
View
|
| NCT00003548 |
|
Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity
|
View
|
| NCT00003546 |
|
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
|
View
|
| NCT00003545 |
|
506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
|
View
|
| NCT00003544 |
|
Irinotecan in Treating Patients With Metastatic Colorectal Cancer
|
View
|
| NCT00003543 |
|
Monoclonal Antibody Therapy Plus Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
|
View
|
| NCT00003542 |
|
Interferon Alfa in Treating Patients With Advanced Kidney Cancer
|
View
|
| NCT00003541 |
|
Combination Chemotherapy Radiation Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma
|
View
|
| NCT00003540 |
|
Gemcitabine in Treating Women With Metastatic Breast Cancer Previously Treated With Doxorubicin and Paclitaxel
|
View
|
| NCT00003539 |
|
Paclitaxel Plus Monoclonal Antibody Therapy in Treating Women With Recurrent or Metastatic Breast Cancer
|
View
|
| NCT00003538 |
|
Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
|
View
|
| NCT00003537 |
|
Antineoplaston Therapy in Treating Adult Patients With Anaplastic Astrocytoma
|
View
|
| NCT00003536 |
|
Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast Cancer
|
View
|
| NCT00003535 |
|
Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma
|
View
|
| NCT00003534 |
|
Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer
|
View
|
| NCT00003533 |
|
Antineoplaston Therapy in Treating Patients With Metastatic Prostate Cancer
|
View
|
| NCT00003532 |
|
Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer
|
View
|
| NCT00003531 |
|
Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic Cancer
|
View
|
| NCT00003530 |
|
Antineoplaston Therapy in Treating Patients With Primary Liver Cancer
|
View
|
| NCT00003528 |
|
Raltitrexed in Treating Children With Refractory Acute Leukemia
|
View
|
| NCT00003526 |
|
Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin
|
View
|
| NCT00003525 |
|
Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix andor Vulva
|
View
|
| NCT00003524 |
|
Antineoplaston Therapy in Treating Patients With Stomach Cancer
|
View
|
| NCT00003523 |
|
Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cancer of the Peritoneum
|
View
|
| NCT00003522 |
|
Antineoplaston Therapy in Treating Patients With Cancer of the Small Intestine
|
View
|
| NCT00003521 |
|
Antineoplaston Therapy in Treating Patients With Soft Tissue Sarcoma
|
View
|
| NCT00003520 |
|
Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer
|
View
|
| NCT00003519 |
|
Combination Chemotherapy in Treating Women With Breast Cancer
|
View
|
| NCT00003518 |
|
Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors
|
View
|
| NCT00003517 |
|
Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
|
View
|
| NCT00003516 |
|
Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
|
View
|
| NCT00003515 |
|
Antineoplaston Therapy in Treating Patients With Metastatic Recurrent or Refractory Primitive Neuroectodermal Tumors
|
View
|
| NCT00003514 |
|
Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy
|
View
|
| NCT00003513 |
|
Antineoplaston Therapy in Treating Patients With Metastatic Recurrent or Refractory Neuroblastoma
|
View
|
| NCT00003512 |
|
Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Waldenstroms Macroglobulinemia
|
View
|
| NCT00003511 |
|
Antineoplaston Therapy in Treating Patients With Multiple Myeloma
|
View
|
| NCT00003509 |
|
Antineoplaston Therapy in Treating Patients With Stage IV Melanoma
|
View
|
| NCT00003508 |
|
Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma
|
View
|
| NCT00003505 |
|
Antineoplaston Therapy in Treating Patients With Primary Central Nervous System Lymphoma
|
View
|
| NCT00003502 |
|
Antineoplaston Therapy in Treating Patients With Mantle Cell Lymphoma
|
View
|
| NCT00003501 |
|
Antineoplaston Therapy in Treating Patients With High-Grade Stage II - Stage IV Non-Hodgkins Lymphoma
|
View
|
| NCT00003500 |
|
Antineoplaston Therapy in Treating Patients With Intermediate-Grade Stage II - IV Non-Hodgkins Lymphoma
|
View
|
| NCT00003499 |
|
Antineoplaston Therapy in Treating Patients With Low-Grade Non-Hodgkins Lymphoma
|
View
|
| NCT00003498 |
|
Antineoplaston Therapy in Treating Patients With Non-Hodgkins Lymphoma
|
View
|
| NCT00003497 |
|
Antineoplaston Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer
|
View
|
| NCT00003496 |
|
Antineoplaston Therapy in Treating Patients With Recurrent or Extensive-Stage Small Cell Lung Cancer
|
View
|
| NCT00003495 |
|
Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer
|
View
|
| NCT00003494 |
|
Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer
|
View
|
| NCT00003493 |
|
Combination Chemotherapy in Treating Patients With Multiple Myeloma
|
View
|
| NCT00003492 |
|
Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer
|
View
|
| NCT00003491 |
|
Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer
|
View
|
| NCT00003490 |
|
Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma
|
View
|
| NCT00003489 |
|
Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer
|
View
|
| NCT00003487 |
|
Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus
|
View
|
| NCT00003486 |
|
Antineoplaston Therapy in Treating Patients With Colon Cancer
|
View
|
| NCT00003485 |
|
Antineoplaston Therapy in Treating Patients With Metastatic or Unresectable Colon Cancer
|
View
|
| NCT00003484 |
|
Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors
|
View
|
| NCT00003483 |
|
Antineoplaston Therapy in Treating Patients With Meningioma
|
View
|
| NCT00003479 |
|
Antineoplaston Therapy in Treating Patients With Ependymoma
|
View
|
| NCT00003478 |
|
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors
|
View
|
| NCT00003477 |
|
Antineoplaston Therapy in Treating Children With Visual Pathway Glioma
|
View
|
| NCT00003476 |
|
Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors
|
View
|
| NCT00003475 |
|
Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors
|
View
|
| NCT00003474 |
|
Antineoplaston Therapy in Treating Adults With ResidualRecurrentProgressive Glioblastoma Multiforme
|
View
|
| NCT00003473 |
|
Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Mixed Gliomas
|
View
|
| NCT00003472 |
|
Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma
|
View
|
| NCT00003471 |
|
Antineoplaston Therapy in Treating Patients With Low-Grade Astrocytoma
|
View
|
| NCT00003470 |
|
Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma
|
View
|
| NCT00003469 |
|
Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System
|
View
|
| NCT00003468 |
|
Antineoplaston Therapy in Treating Children With Low-Grade Astrocytoma
|
View
|
| NCT00003467 |
|
Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma
|
View
|
| NCT00003466 |
|
Temozolomide in Treating Patients With Progressive Low-Grade Glioma
|
View
|
| NCT00003465 |
|
Temozolomide in Treating Patients With Anaplastic Oligodendroglioma
|
View
|
| NCT00003464 |
|
Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme
|
View
|
| NCT00003463 |
|
Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas
|
View
|
| NCT00003462 |
|
Intrathecal Busulfan in Treating Patients With Recurrent Refractory or Metastatic Leptomeningeal Tumors
|
View
|
| NCT00003461 |
|
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors
|
View
|
| NCT00003460 |
|
Antineoplaston Therapy in Treating Children With Primitive Neuroectodermal Tumors
|
View
|
| NCT00003459 |
|
Antineoplaston Therapy in Treating Patients With Brain Stem Glioma
|
View
|
| NCT00003458 |
|
Antineoplaston Therapy in Treating Children With Brain Tumors
|
View
|
| NCT00003457 |
|
Antineoplaston Therapy in Treating Patients With Brain Tumors
|
View
|
| NCT00003456 |
|
Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme
|
View
|
| NCT00003455 |
|
Antineoplaston Therapy in Treating Women With Advanced Breast Cancer
|
View
|
| NCT00003454 |
|
Antineoplaston Therapy in Treating Women With Stage IV Breast Cancer
|
View
|
| NCT00003453 |
|
Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer
|
View
|
| NCT00003452 |
|
Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Bladder
|
View
|
| NCT00003451 |
|
Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer
|
View
|
| NCT00003450 |
|
Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal Cancer
|
View
|
| NCT00003449 |
|
Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer
|
View
|
| NCT00003447 |
|
Vinorelbine andor Gemcitabine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
|
View
|
| NCT00003446 |
|
Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer
|
View
|
| NCT00003445 |
|
Docetaxel in Treating Patients With Advanced Cancer of the Cervix
|
View
|
| NCT00003444 |
|
Interferon Alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck Under the Arm or in the Groin
|
View
|
| NCT00003443 |
|
Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
|
View
|
| NCT00003441 |
|
Irofulven in Treating Patients With Metastatic Colorectal Cancer
|
View
|
| NCT00003440 |
|
Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2Neu Breast Cancer That is Inoperable Recurrent or Metastatic
|
View
|
| NCT00003439 |
|
Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer
|
View
|
| NCT00003437 |
|
Hormone Therapy Plus Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
|
View
|
| NCT00003436 |
|
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia
|
View
|
| NCT00003435 |
|
Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer
|
View
|
| NCT00003434 |
|
Biological Therapy in Stage I Stage II or Stage III Surgically Resected Pancreatic Cancer
|
View
|
| NCT00003433 |
|
Immunotherapy in Treating Patients With Resected Liver Metastases From Colon Cancer
|
View
|
| NCT00003432 |
|
Immunotherapy in Treating Patients With Metastatic Breast Cancer
|
View
|
| NCT00003431 |
|
Flt3L in Treating Patients With Metastatic Colorectal Cancer
|
View
|
| NCT00003430 |
|
L-778123 in Treating Patients With Recurrent or Refractory Solid Tumors
|
View
|
| NCT00003429 |
|
PET Scans in Diagnosing Primary or Recurrent Cervical Cancer in Patients Who Are Undergoing Surgery
|
View
|
| NCT00003428 |
|
Hormone Therapy in Treating Women With Breast Cancer
|
View
|
| NCT00003427 |
|
Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer
|
View
|
| NCT00003426 |
|
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
|
View
|
| NCT00003425 |
|
Phase III Study of Escalating-Dose Melphalan wAutologous SCS Amifostine Cytoprotect
|
View
|
| NCT00003424 |
|
Tamoxifen in Treating Patients With Primary Liver Cancer
|
View
|
| NCT00003423 |
|
Combination Chemotherapy in Treating Children With Non-Hodgkins Lymphoma
|
View
|
| NCT00003422 |
|
Radiation Therapy Before Surgery Compared With Chemotherapy Plus Radiation After Surgery in Treating Patients With Rectal Cancer That Can Be Surgically Removed
|
View
|
| NCT00003421 |
|
Combination Chemotherapy in Treating Patients With Advanced Hodgkins Disease
|
View
|
| NCT00003420 |
|
CT Scans in Treating Patients With Stage I Testicular Cancer After Undergoing Orchiectomy
|
View
|
| NCT00003419 |
|
Antiviral Therapy in Treating Patients With Slowly Progressing HIV-Related Kaposis Sarcoma
|
View
|
| NCT00003418 |
|
Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer
|
View
|
| NCT00003417 |
|
Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme
|
View
|
| NCT00003416 |
|
S9805 High-Dose Melphalan Plus Peripheral Stem Cell Transplantation Followed by Interferon Alfa in Treating Patients With Waldenstroms Macroglobulinemia
|
View
|
| NCT00003415 |
|
Amifostine Plus Topotecan in Treating Patients With Myelodysplastic Syndrome
|
View
|
| NCT00003414 |
|
Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkins Disease
|
View
|
| NCT00003413 |
|
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
|
View
|
| NCT00003412 |
|
Interleukin-12 in Treating Women With Metastatic Breast Cancer Who Have Received High-Dose Chemotherapy and Peripheral Stem Cell Transplantation
|
View
|
| NCT00003411 |
|
Radiation Therapy in Treating Patients With Bile Duct Gallbladder or Pancreatic Cancer
|
View
|
| NCT00003410 |
|
Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas
|
View
|
| NCT00003409 |
|
Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
|
View
|
| NCT00003408 |
|
Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer
|
View
|
| NCT00003407 |
|
Amifostine High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML
|
View
|
| NCT00003406 |
|
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer
|
View
|
| NCT00003405 |
|
Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia
|
View
|
| NCT00003404 |
|
Radiation Therapy After Surgery in Treating Women With Phyllodes Tumor of the Breast
|
View
|
| NCT00003403 |
|
GPX-100 in Treating Patients With Solid Tumors
|
View
|
| NCT00003402 |
|
Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkins Lymphoma or Chronic Lymphocytic Leukemia
|
View
|
| NCT00003401 |
|
Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma
|
View
|
| NCT00003400 |
|
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer
|
View
|
| NCT00003399 |
|
Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma
|
View
|
| NCT00003398 |
|
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
|
View
|
| NCT00003397 |
|
Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkins Lymphoma
|
View
|
| NCT00003396 |
|
Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
|
View
|
| NCT00003395 |
|
Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer
|
View
|
| NCT00003394 |
|
Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
|
View
|
| NCT00003392 |
|
High-Dose Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer
|
View
|
| NCT00003391 |
|
Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
|
View
|
| NCT00003390 |
|
6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Kidney Cancer
|
View
|
| NCT00003389 |
|
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkins Lymphoma
|
View
|
| NCT00003388 |
|
Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma
|
View
|
| NCT00003387 |
|
Carboplatin Paclitaxel and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During Surgery
|
View
|
| NCT00003386 |
|
Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
|
View
|
| NCT00003385 |
|
Combination Chemotherapy in Treating Patients With Untreated Ovarian Peritoneal or Fallopian Tube Cancer
|
View
|
| NCT00003384 |
|
Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia andor Cancer
|
View
|
| NCT00003382 |
|
Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer
|
View
|
| NCT00003381 |
|
Quality of Life Assessment of Patients Receiving Treatment for Esophageal Cancer Companion to CALGB-9781
|
View
|
| NCT00003380 |
|
Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian Fallopian Tube or Peritoneal Cancer
|
View
|
| NCT00003379 |
|
Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer
|
View
|
| NCT00003378 |
|
Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer
|
View
|
| NCT00003377 |
|
Radiation Therapy Paclitaxel and Cisplatin in Treating Patients With Cancer of the Cervix
|
View
|
| NCT00003376 |
|
Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium
|
View
|
| NCT00003375 |
|
Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma
|
View
|
| NCT00003372 |
|
Topotecan in Treating Patients With Recurrent Brain Tumors
|
View
|
| NCT00003370 |
|
Irofulven in Treating Children With Recurrent or Refractory Solid Tumors
|
View
|
| NCT00003369 |
|
S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic Recurrent or Refractory Cervical Cancer
|
View
|
| NCT00003368 |
|
Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis
|
View
|
| NCT00003367 |
|
Diet and PSA Levels in Patients With Prostate Cancer
|
View
|
| NCT00003365 |
|
Sulindac and Plant Compounds in Preventing Colon Cancer
|
View
|
| NCT00003364 |
|
Radiation Therapy Plus Combination Chemotherapy In Treating Patients With Limited Stage Small Cell Lung Cancer
|
View
|
| NCT00003362 |
|
Vaccine Therapy Plus Immune Adjuvants in Treating Patients With Advanced Melanoma
|
View
|
| NCT00003361 |
|
Decitabine in Treating Patients With Myelodysplastic Syndrome
|
View
|
| NCT00003360 |
|
Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Colorectal Cancer
|
View
|
| NCT00003359 |
|
T138067 Sodium in Treating Patients With Advanced Refractory Cancer
|
View
|
| NCT00003358 |
|
Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial Fallopian Tube or Primary Peritoneal Cancer
|
View
|
| NCT00003357 |
|
Vaccine Therapy Plus QS21 in Treating Women With Breast Cancer Who Have No Evidence of Disease
|
View
|
| NCT00003356 |
|
Rituximab Plus Interleukin-2 in Treating Patients With Lymphoma
|
View
|
| NCT00003354 |
|
Conventional Surgery Compared With Laparoscopic-Assisted Surgery in Treating Patients With Colorectal Cancer
|
View
|
| NCT00003353 |
|
High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis
|
View
|
| NCT00003352 |
|
Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer
|
View
|
| NCT00003351 |
|
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
|
View
|
| NCT00003350 |
|
Paclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposis Sarcoma
|
View
|
| NCT00003348 |
|
Carmustine Plus O6-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain
|
View
|
